Search

everythinglearnresearchcommunity

for

Search:↓

Vitamin D and estrogen may help protect heart and kidney health, and maintaining sufficient vitamin D levels could be especially beneficial for African Americans, postmenopausal women, and people with chronic kidney disease.

A boy with toxic shock syndrome had severe heart rhythm problems but recovered with treatment.

Carriers of a specific gene mutation have subtle skin changes without visible symptoms.

The conclusion is that 24 weeks of low-dose oral minoxidil is safe for men with hair loss, with no significant changes in heart rate or blood pressure.

Targeting NCoR1 can help treat heart enlargement and dysfunction.

Leuprolide may better manage cholesterol and blood pressure in PCOS than spironolactone.

Anabolic-androgenic steroid abuse can cause heart damage and sudden death.

Testosterone treatment may affect heart response to stress in transgender men.

Adults with Tatton-Brown-Rahman syndrome may have serious heart problems and need lifelong heart monitoring.

Alopecia, especially androgenic, may increase cardiovascular risk, but more research is needed.

Men with early-onset hair loss have less cardiometabolic benefit from bromocriptine.

Male hormones may play a role in the development of heart disease, and more research is needed to understand their effects.

Some heart drugs show promise for other conditions, but more research is needed to confirm their effectiveness and safety.

Using minoxidil on dogs can cause serious cardiovascular damage, including arterial injury and hemorrhagic lesions.

Testosterone is linked to cardiovascular risk factors and stroke, but its exact role is unclear.

People with alopecia are at higher risk for heart disease and have more heart-related risk factors.

Minoxidil may cause heart changes; use caution and monitor patients with heart conditions.

Women generally handle heart enlargement better than men, but it's riskier for them if it occurs; hormones like estrogen offer some protection.

Treatments for PCOS aim to reduce androgen levels and improve insulin sensitivity to lower cardiometabolic risk.

Healing of heart and skin wounds in animals are similar.

Obese and non-obese women with PCOS have higher heart risk markers, especially if they are obese.

Balding men have higher heart disease risk.

Wnt4 is essential for heart repair and could be a target for heart disease treatment.

Dexpanthenol helps protect the heart from damage by reducing inflammation and stress.

Gender-affirming hormone therapy may increase heart disease risk in transgender individuals.

Wnt/β-catenin signaling is crucial for heart development and could help improve heart repair.

New methods improve stem cell delivery for heart disease, but challenges remain.

High androgen levels in postmenopausal women may suggest an ovarian tumor, and removing it can improve heart and metabolic health.

Postmenopausal women with past hirsutism or irregular periods have more heart and lung diseases.

The review concludes that more research is needed to better improve the health outcomes for people with Polycystic Ovarian Syndrome.